Roche Holding AG (LTS:0TDF) FFO


LTS:0TDF Roche Holding AG LTS:0TDF
77 GF Score
Price $51.85
GF Value $42.15
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Roche Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0TDF
77GF Score
Roche Holding AG LTS:0TDF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (LTS:0TDF) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of $51.85 is trading 23% above its estimated GF Value™ of $42.15. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for LTS:0TDF:

  • FFO:
  • GF Value™: $42.15 vs. price of $51.85 (23% above fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the LTS:0TDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
77GF Score

Get the complete analysis for LTS:0TDF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$51.85
Price
$42.15
GF Value